1. El consumo regular de un caldo funcional enriquecido con fosfofructooligosacáridos aumenta los niveles de las hormonas relacionadas con la saciedad en las personas sanas. Ensayo clínico aleatorizado y controlado.
- Author
-
Arcos Castellanos, Lucía, López Plaza, Bricia, Morato Martínez, Marina, Valero Pérez, Marlhyn, Palma Milla, Samara, and Gómez Candela, Carmen
- Subjects
- *
APPETITE , *FAT , *VISUAL analog scale , *GHRELIN , *SEDENTARY lifestyles , *LEPTIN , *INSULIN , *MALTODEXTRIN - Abstract
Introduction: excess weight represents a public health problem due to its associated risk factors. A sedentary lifestyle, an inadequate diet or a decrease in the feeling of satiety are some of the causes. Objetives: to evaluate the satiating properties of the consumption of a functional Iberian broth enriched with phospho-fructooligosaccharides (FOS) in healthy people through the plasma concentration of hormones involved in appetite. Material and methods: acute, crossover, randomized, double-blind and controlled nutritional clinical trial carried out in 18 randomized participants in two treatment sequences (functional broth (CF), composed of 5.6 g POS/100 g and control broth (CC), with 0.4 g of maltodextrin/100 g) with 14 days of washing in between. Satiety-related parameters (glucose, insulin, leptin, ghrelin, GLP-1, PYY) and visual analog scales (VAS) were measured. Results: the percentage of body fat decreased in those who took the CF (-0.15 ± 0.32 vs 0.09 ± 0.52) (p < 0.05). Leptin concentration was higher with CF (p < 0.001), which was shown at time points -30 (p < 0.001), 0 (p < 0.001), 30 (p = 0.026) and 120 (p = 0.049) when compared to CC. The areas under the curve (AUC) for GLP-1 (p = 0.0033) and PYY (p = 0.022) were higher for CF as compared to CC. Conclusion: consumption of an Iberian broth enriched with POS improves the plasma concentration of hormones involved in the control of satiety, and reduces the amount of body fat. This result could have beneficial effects for the prevention and treatment of overweight. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF